Brought to you by:
Machine learning-based model could aid in determining EVAR suitability
Researchers at the University Medical Center Groningen (Groningen, The Netherlands) and the University of Twente (Enschede, The Netherlands) have developed a prediction model that they claim could assist in the preoperative identification of patients who are unlikely to achieve sufficient…
One-year STRIDE study data show ‘meaningful’ limb salvage, mortality and QoL outcomes
One-year outcomes from the STRIDE study of the Indigo aspiration thrombectomy system (Penumbra) for lower-extremity acute limb ischemia (ALI) showed target limb salvage and mortality rates of 88.5% and 12%, respectively. The data were revealed by Thomas Maldonado, MD, professor…
PRESERVE II trial shows robust five-year outcomes
Five-year outcomes the PRESERVE II pivotal trial of Cook Medical’s Zenith branch iliac graft (ZBIS) demonstrate “sustained safety and effectiveness” when combined with the iCast (Getinge) covered stent for the treatment of aortoiliac aneurysms and preservation of hypogastric artery perfusion,…
‘Well, here we are—but right now I wish I wasn’t’: Early-career errors
On Friday, June 21, the Society for Vascular Surgery (SVS) Young Surgeons Section (YSS) held their session at the 2024 Vascular Annual Meeting (VAM). The session began with Chelsea Dorsey, MD, highlighting the YSS’ achievements from the last year including…
SVS Annual Business Meeting showcases 2024 Foundation award recipients
The Society for Vascular Surgery (SVS) convened its Annual Business Meeting at the Vascular Annual Meeting (VAM) on June 22 in Chicago. A highlight of the event was the announcement of the 2023–2024 award recipients by the outgoing Foundation Chair…
SVS Women’s Section delves into vascular trauma treatment intricacies amid ‘paucity of literature’
“Life over limb”—that was one of the key messages to emerge from the VAM 2024 SVS Women’s Section session that placed a lens over vascular trauma treatment. Misty Humphries, MD, associate professor of surgery at University of California Davis in…
Vascular care is a ‘team sport’ founded on infrastructure, personnel and standards
The E. Stanley Crawford critical issues forum at VAM 2024 in Chicago—which featured the tagline ‘Quality Care Everywhere’—underscored the importance of standards, infrastructure, personnel and verification programs in vascular surgery. Multiple speakers throughout the session described vascular care as a…
Government Grand Rounds: The role of stakeholders in legislative and administrative engagement
Stakeholder organizations such as the Society for Vascular Surgery (SVS) play a crucial role in shaping healthcare policies and ensuring that the voices of medical professionals are heard in the legislative and administrative processes. These organizations utilize several key methods…
Acellular tissue-engineered vessel granted FDA Regenerative Medicine Advanced Therapy designation for advanced PAD
Humacyte recently announced it has been granted Regenerative Medicine Advanced Therapy (RMAT) designation from the US Food and Drug Administration (FDA) for its investigational acellular tissue-engineered vessel (ATEV), designed to treat patients with advanced peripheral arterial disease (PAD). This RMAT…
Life Seal Vascular awarded NSF SBIR grant to advance sac management technology for EVAR
Life Seal Vascular recently announced that it has been awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant. The funding will be used to accelerate the development of the company’s endovascular aneurysm repair (EVAR) technology. “We are…